Bioengineered Protein Drugs Market Overview - Key Futuristic Trends and Competitive Landscape 2025
August 23, 2017 at 00:40 AM EDT
Albany, NY -- (SBWIRE) -- 08/22/2017 -- Some of the prominent participants in the global bioengineered protein drugs market are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Amgen, Inc., Bayer AG, Merck & Co., Inc., Dr. Reddy's Laboratories Ltd., Biocon Ltd., Eli Lilly and Company, Sanofi, Fresenius Kabi, GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Panacea Biotec, ProBioGen AG, and Reliance Life Sciences Pvt. Ltd.